Established nine years ago and headquartered at AkzoNobel's site in Columbus, Mississippi, the joint venture owned and controlled the 70,000 short tons per annum (nameplate capacity)  hydrogen peroxide manufacturing facility.

peroxide is a key component of AkzoNobel's bleaching chemicals product portfolio and is marketed by the company’s Pulp and Performance Chemicals business. It has essential applications in various markets, notably pulp bleaching, chemical processing and mining.

"This deal supports the strategic growth objectives for our bleaching chemicals activities. The hydrogen peroxide market in North America has improved significantly in recent years, with AkzoNobel well placed to grow the business," said Werner Fuhrmann, AkzoNobel's Executive Committee member responsible for Specialty Chemicals. "It will also enable us to strengthen our integrated platform for the production of hydrogen peroxide and sodium chlorate at the Columbus site."

details of this transaction are not disclosed.